Should Opioid Addicts Be Forced to Undergo Medical Treatment?

According to a forthcoming study in the Journal of Law, Medicine, and Ethics, there’s little evidence that opioid addicts benefit from involuntary commitment, and the “legal and ethical” concerns raised by such strategies should make policymakers think twice about employing them.

Trump Opioid Plan Includes a Windfall for Vivitrol

The White House’s national strategy to combat the opioid crisis, unveiled last week, would expand a particular kind of addiction treatment in federal criminal justice settings: a single drug, manufactured by a single company, with mixed views on the evidence regarding its use. The drug is Vivitrol, manufactured by Alkermes, a Massachusetts pharmaceutical company.


‘I’m Not Gonna Walk by Someone Dying’

A New York State pilot program to make naloxone kits available to inmates on their release from prison is a “promising” model for other states seeking to reduce opioid deaths among America’s most vulnerable population, says the Vera Institute of Justice.

AR Cities, Counties Unite to Sue Opioid Industry

The suit, described as unique by state officials, names 59 companies and six individuals, including Purdue Pharma, Cephalon, Endo, Janssen, and Teva Pharmaceuticals. Arkansas ranks 2nd in the nation behind Alabama for misuse of opioids.